pizotyline has been researched along with Malignant Carcinoid Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| May, B | 1 |
| Autenrieth, G; Baur, X; Bortsch, A; Jacob, K; Neudert, J; Schneider, B; Werdan, K | 1 |
1 review(s) available for pizotyline and Malignant Carcinoid Syndrome
| Article | Year |
|---|---|
[Carcinoid: diagnosis and therapy].
Topics: Aprotinin; Bradykinin; Carcinoid Heart Disease; Carcinoid Tumor; Cyproheptadine; Diagnosis, Differential; Ergot Alkaloids; Humans; Hydroxyindoleacetic Acid; Kallidin; Malignant Carcinoid Syndrome; Methylprednisolone; Methysergide; Phentolamine; Pizotyline; Serotonin | 1975 |
1 other study(ies) available for pizotyline and Malignant Carcinoid Syndrome
| Article | Year |
|---|---|
[Carcinoid syndrome with a course of more than 10 years].
Topics: Adult; Antineoplastic Agents; Female; Follow-Up Studies; Humans; Malignant Carcinoid Syndrome; Octreotide; Pizotyline; Somatostatin | 1988 |